Although cough is a defence mechanism to clear the airways, if it becomes excessive or persistent it may cause hyperventilation which, in combination with reflex cardiovascular changes, can exacerbate ...
WASHINGTON--(BUSINESS WIRE)--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, presented positive results from a Phase 2 proof-of-concept study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback